References
- Isaacson, P.G. (1999) "Gastrointestinal lymphomas of T- and B-cell types", Modern Pathology 12, 151–158.
- Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hennelink, H.K., Vardiman, J., Lister, T.A. and Bloomfield, C.D. (1999) "World Health Organization classification of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting—Airlie House, Virginia, November 1997", Journal of Clinical Oncology 17, 3835–3849,
- Gale, J., Simmons, P.D., Mead, G.M., Sweetenham, J.W. and Wright, D.H. (2000) "Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center", Journal of Clinical Oncology 18, 795–803.
- Ketterer, N., Sonet, A., Dumontet, C., Moullet, I., Thieblemont, C., Espinouse, D., Bouafia, F., Coiffier, B. and Salles, G. (1999) "Toxicities after blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution", Bone Marrow Transplantation 23, 1309–1315.
- Lennard, A.L., White, J. and Tiplady, C. on behalf of the Therapy Working Party of the Scotland and Newcastle Lymphoma Group (S.N.L.G) (2002) "Prospective evaluation of a novel treatment protocol for intestinal T cell NHL", Annals of Oncology 13, 43 (abstr. 130).
- Jantunen, E., Kuittinen, T. and Nousiainen, T. (2003) "BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single center analysis on toxicity and efficacy", Leukemia & Lymphoma, In press.
- Capelli, D., Santini, G., De Souza, C., Poloni, A., Marino, G., Montanan, M., Lucesole, M., Brunori, M., Massidda, D., Offidani, M., Leoni, P. and Olivieri, A. (2000) "Amifostine can reduce mucosa] damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study", British Journal of Haematology 110, 300–307.